BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18581715)

  • 21. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.
    Huang DT; Traub D
    Prog Cardiovasc Dis; 2008; 51(3):229-36. PubMed ID: 19026857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrical storm secondary to hypokaliemia in a patient with implantable cardioverter defibrillator].
    Kachboura S; Ben Halima A; Ben Miled M
    Ann Cardiol Angeiol (Paris); 2010 Feb; 59(1):54-8. PubMed ID: 20004887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrical storms and their prognostic implications.
    Awan ZA; ul Hassan M; Bangash K; Shah B; Noor L
    J Ayub Med Coll Abbottabad; 2009; 21(3):155-8. PubMed ID: 20929037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study.
    Yap SC; Roos-Hesselink JW; Hoendermis ES; Budts W; Vliegen HW; Mulder BJ; van Dijk AP; Schalij MJ; Drenthen W
    Eur Heart J; 2007 Aug; 28(15):1854-61. PubMed ID: 17030523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of electrical storm in implantable cardioverter-defibrillator recipients].
    Santomauro M; Duilio C; Tecchia LB; Di Mauro P; Iapicca G; Auricchio L; Filardi PP
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):37S-41S. PubMed ID: 21416825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter defibrillator storm: nursing care issues for patients and families.
    O'Brien MC; Langberg J; Valderrama AL; Kirkendoll K; Romeiko N; Dunbar SB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):9-16, ix. PubMed ID: 15749396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac resynchronisation therapy as a cause of the electrical storm].
    Krupa W; Lackowski J; Sielski S; Dobosiewicz R; Kubica J
    Kardiol Pol; 2007 Nov; 65(11):1350-3. PubMed ID: 18058584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal variations of ventricular arrhythmia clusters in defibrillator recipients.
    Stuber T; Eigenmann C; Delacrétaz E
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):816-20. PubMed ID: 16922996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
    Germano JJ; Reynolds M; Essebag V; Josephson ME
    Am J Cardiol; 2006 Apr; 97(8):1255-61. PubMed ID: 16616037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    Int J Cardiol; 2008 May; 126(1):101-7. PubMed ID: 17499864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.
    Dworschak M; Franz M; Czerny M; Gorlitzer M; Blaschek M; Grubhofer G; Haider W
    Crit Care Med; 2003 Aug; 31(8):2085-9. PubMed ID: 12973163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
    Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
    Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
    Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
    Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
    Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial.
    Chevalier P; Cottraux J; Mollard E; Sai N; Brun S; Burri H; Restier L; Adeleine P
    Am Heart J; 2006 Jan; 151(1):191. PubMed ID: 16368316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.